Cargando…

The mitochondrial genetic landscape in neuroblastoma from tumor initiation to relapse

Little is known about changes within the mitochondrial (mt) genome during tumor progression in general and during initiation and progression of neuroblastoma (NB) in particular. Whole exome sequencing of corresponding healthy tissue, primary tumor and relapsed tumor from 16 patients with NB revealed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riehl, Lara M., Schulte, Johannes H., Mulaw, Medhanie A., Dahlhaus, Meike, Fischer, Matthias, Schramm, Alexander, Eggert, Angelika, Debatin, Klaus-Michael, Beltinger, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872737/ https://www.ncbi.nlm.nih.gov/pubmed/26735174 http://dx.doi.org/10.18632/oncotarget.6776

Ejemplares similares

Targeted parallel DNA sequencing detects circulating tumor‐associated variants of the mitochondrial and nuclear genomes in patients with neuroblastoma
por: Riehl, Lara, et al.
Publicado: (2022)

PPP2CA Is a Novel Therapeutic Target in Neuroblastoma Cells That Can Be Activated by the SET Inhibitor OP449
por: Galiger, Celimene, et al.
Publicado: (2022)

CD57(high) Neuroblastoma Cells Have Aggressive Attributes Ex Situ and an Undifferentiated Phenotype in Patients
por: Schlitter, Anne-Marie, et al.
Publicado: (2012)

CHD5 inhibits metastasis of neuroblastoma
por: Laut, Astrid K., et al.
Publicado: (2021)

The survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells
por: Galiger, Celimene, et al.
Publicado: (2023)

γ-secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets
por: Dorneburg, Carmen, et al.
Publicado: (2016)

Genomic ALK alterations in primary and relapsed neuroblastoma
por: Rosswog, Carolina, et al.
Publicado: (2023)

Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells
por: Pajtler, Kristian W., et al.
Publicado: (2014)

Targeting tachykinin receptors in neuroblastoma
por: Henssen, Anton G., et al.
Publicado: (2016)

Mitophagy switches cell death from apoptosis to necrosis in NSCLC cells treated with oncolytic measles virus
por: Xia, Mao, et al.
Publicado: (2014)

Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma
por: Schulte, Johannes H., et al.
Publicado: (2010)

The MicroRNA Landscape of MYCN-Amplified Neuroblastoma
por: Misiak, Danny, et al.
Publicado: (2021)

Discovery of Spatial Peptide Signatures for Neuroblastoma Risk Assessment by MALDI Mass Spectrometry Imaging
por: Wu, Zhiyang, et al.
Publicado: (2021)

Sinusoidal Obstruction Syndrome Following Myeloablative Therapy and Tranexamic Acid Treatment for Hemorrhage in Two Patients with Neuroblastoma
por: Zirngibl, Felix, et al.
Publicado: (2020)

Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies
por: Xu, Chun, et al.
Publicado: (2018)

Clinical Presentation and Management of a Dinutuximab Beta Extravasation in a Patient with Neuroblastoma
por: Launspach, Michael, et al.
Publicado: (2021)

The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models
por: Pajtler, Kristian W, et al.
Publicado: (2016)

Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN
por: Fuchs, Steffen, et al.
Publicado: (2023)

Aging of the Hematopoietic Stem Cell Niche: New Tools to Answer an Old Question
por: Matteini, Francesca, et al.
Publicado: (2021)

Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
por: De Preter, Katleen, et al.
Publicado: (2006)

Generation of Murine Sympathoadrenergic Progenitor-Like Cells from Embryonic Stem Cells and Postnatal Adrenal Glands
por: Saxena, Shobhit, et al.
Publicado: (2013)

Correction: Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
por: De Preter, Katleen, et al.
Publicado: (2007)

Trail (TNF-related apoptosis-inducing ligand) induces an inflammatory response in human adipocytes
por: Zoller, Verena, et al.
Publicado: (2017)

The mutational landscape of MYCN, Lin28b and ALK(F1174L) driven murine neuroblastoma mimics human disease
por: De Wilde, Bram, et al.
Publicado: (2017)

Generic wound signals initiate regeneration in missing-tissue contexts
por: Owlarn, Suthira, et al.
Publicado: (2017)

Novel Therapies for Relapsed and Refractory Neuroblastoma
por: Zage, Peter E.
Publicado: (2018)

Modulation of Neuroblastoma Disease Pathogenesis By An Extensive Network of Epigenetically Regulated MicroRNAs
por: Das, Sudipto, et al.
Publicado: (2012)

Focal DNA Copy Number Changes in Neuroblastoma Target MYCN Regulated Genes
por: Kumps, Candy, et al.
Publicado: (2013)

RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia Initiation
por: Pan, Leiling, et al.
Publicado: (2023)

Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing
por: Szymansky, Annabell, et al.
Publicado: (2021)

Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry
por: Jazmati, Danny, et al.
Publicado: (2022)

The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia
por: Künkele, Annette, et al.
Publicado: (2013)

Mutational topography reflects clinical neuroblastoma heterogeneity
por: Rodriguez-Fos, Elias, et al.
Publicado: (2023)

GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma
por: Zirngibl, Felix, et al.
Publicado: (2021)

Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance
por: Dorel, Mathurin, et al.
Publicado: (2021)

Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse
por: Flaadt, Tim, et al.
Publicado: (2023)

The genetic landscape of high-risk neuroblastoma
por: Pugh, Trevor J., et al.
Publicado: (2013)

Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival
por: Thole, Theresa M, et al.
Publicado: (2017)

Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma
por: Arnhold, Viktor, et al.
Publicado: (2017)

Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome
por: Padovan-Merhar, Olivia M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p2sp5hqd2hdo835egotbsbmp76